サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654421

ELISpotとFluorospotアッセイの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

ELISpot And Fluorospot Assay Market Size, Share & Trends Analysis Report By Product (Prospective, Retrospective), By Application (Oncology, Neurology, Cardiology), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ELISpotとFluorospotアッセイの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2025年01月31日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ELISpotとFluorospotアッセイの市場動向

世界のELISpotとFluorospotアッセイ市場規模は、2024年に3億1,180万米ドルと推定され、2025～2030年にかけてCAGR 6.3％で成長すると予測されています。

この成長は、慢性疾患や感染症の増加、創薬活動の増加、研究や診断における採用の増加、前臨床や臨床で規制されるバイオアナリシスの拡大に起因しています。ELISpotとFluorospotアッセイは免疫応答にアクセスするために使用され、がんを含む免疫系に対する様々な疾患の影響を理解する上で重要性を増しています。

ELISpotとFluorospotアッセイは、がん免疫療法の適切なメディエーターとして機能する、自然に存在する腫瘍反応性T細胞の検出と特性分析に使用されます。さらに、これらのアッセイは、エピトープマッピング、腫瘍抗原の同定、ワクチン誘発T細胞とB細胞応答のモニターにも使用されています。さらに、肝細胞がん（HCC）と子宮頸がんの開発は、それぞれヒトパピローマウイルス（HPV）とB型肝炎ウイルス（HBV）の高リスク感染と密接に関連しています。腫瘍特異的ワクチンは動物モデルや細胞株で頻繁に検査されています。例えば、HPVワクチンはIFN-YとIL-2 ELISPOTアッセイを用いてマウスや細胞株で評価されました。

転移性子宮頸がん患者におけるIFN-Y ELISPOTアッセイによる抗原特異的T細胞応答の開発は、研究者が新しい治療戦略を開発するのに役立っています。研究者たちは、腫瘍DNAまたは腫瘍ホモジネートを負荷した樹状細胞を通して腫瘍特異的細胞傷害性Tリンパ球（CTL）を誘導することにより、がんの進行を阻止することに取り組んでいます。もう一つのアプローチは、腫瘍抗原をコードするアデノウイルスベクターなどのウイルスベクターによる遺伝子ワクチンの作製です。腫瘍特異的CTLの反応は、ELISPOTアッセイで決定することができます。

IFN-Y ELISPOTアッセイは、転移性黒色腫と腎細胞がん患者における高用量IL-2治療の免疫学的有効性を評価するためにも使用されます。こうしたがん研究におけるELISpotとFluorospotアッセイの用途の増加は、がん罹患率の増加とともに需要を牽引すると予想されます。米国国立がんラボのデータによると、年間のがん罹患者数は2,990万人に増加し、がんに関連した死亡者数は1,530万人に達すると予測されています。このようながん患者の急増が、予測期間中の市場成長の原動力になると予想されます。

これらのアッセイは、潜在的な薬剤が免疫系に及ぼす影響を評価するための強力なツールとなります。ELISpotは、免疫不全症候群（AIDS）、マラリア、結核、がん、インフルエンザなど様々な疾患のワクチン開発において重要なツールとして台頭しています。ELISpotテストは、ワクチンを評価する臨床検査で広く利用されています。世界保健機関（WHO）の国際臨床検査登録プラットフォーム（ICTRP）のデータによると、2022年だけでも世界で5万4,952件の臨床検査が実施されました。こうした臨床検査や創薬活動の増加は、ELISpotアッセイやFluorospotアッセイの需要を増加させ、市場成長を促進すると予想されます。

さらに、複数の市場参入企業が、さまざまな健康状態に対するELISpotとFluorospotアッセイによる先進的ソリューションの開発に向けた取り組みを強化しており、これが市場成長をさらに促進しています。例えば、2023年11月、Revvityは、潜伏結核スクリーニングのためのFDA承認ELISPOT技術によるT-SPOT検査のインドでの発売を発表しました。この検査は標準化されたサンプルを使用するため、検査性能に影響を与える血液因子の影響が少なく、T細胞数の正常化も可能です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ELISpotとFluorospotアッセイ市場の変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 ELISpotとFluorospotアッセイ市場：製品ビジネス分析

  • 製品市場シェア、2024年と2030年
  • 製品セグメントダッシュボード
  • 市場規模と予測と動向分析、製品別、2018～2030年
  • アッセイキット
  • 分析装置
  • 補助製品

第5章 ELISpotとFluorospotアッセイ市場：用途ビジネス分析

  • 用途市場シェア、2024年と2030年
  • 用途セグメントダッシュボード
  • 市場規模と予測と動向分析、用途別、2018～2030年
  • 研究用途
  • 診断用途

第6章 ELISpotとFluorospotアッセイ市場：最終用途ビジネス分析

  • 最終用途市場シェア、2024年と2030年
  • 最終用途セグメントダッシュボード
  • 市場規模と予測と動向分析、最終用途別、2018～2030年
  • 病院と臨床検査室
  • 学術研究機関
  • バイオ医薬品会社

第7章 ELISpotとFluorospotアッセイ市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2018～2030年
  • 北米
    • 国別、2018～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 国別、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 国別、2018～2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • 国別、2018～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 国別、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • BD
    • U-CyTech
    • Cellular Technology Limited
    • Mabtech
    • Abcam Limited
    • Autoimmun Diagnostika GmbH
    • Lophius Biosciences GmbH
    • Bio-Connect BV
    • Oxford Immunotec
    • Bio-Techne Corporation
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global ELISpot and fluorospot assay market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 5 Global ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 11 U.S. ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 12 U.S. ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 15 Canada ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Mexico ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 18 Mexico ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 19 Mexico ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Europe ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 25 UK ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 26 UK ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 30 France ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 31 France ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 32 France ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Italy ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 34 Italy ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 38 Spain ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Norway ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 40 Norway ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 41 Norway ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Denmark ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 43 Denmark ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 44 Denmark ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Sweden ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 46 Sweden ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 47 Sweden ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 53 Japan ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 54 Japan ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 55 China ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 56 China ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 57 China ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 58 India ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 59 India ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 60 India ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Australia ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 62 Australia ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 63 Australia ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 64 South Korea ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 65 South Korea ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 66 South Korea ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 67 Thailand ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 68 Thailand ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 69 Thailand ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Latin America ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 72 Latin America ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 73 Latin America ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Brazil ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 75 Brazil ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 76 Brazil ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Argentina ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 78 Argentina ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 84 South Africa ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 85 South Africa ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Africa ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 90 UAE ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 91 UAE ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 ELISpot and fluorospot assay market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product and application outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 ELISpot and fluorospot assay market dynamics
  • Fig. 13 ELISpot and fluorospot assay market: Porter's five forces analysis
  • Fig. 14 ELISpot and fluorospot assay market: PESTLE analysis
  • Fig. 15 ELISpot and fluorospot assay market: Product segment dashboard
  • Fig. 16 ELISpot and fluorospot assay market: Product market share analysis, 2024 & 2030
  • Fig. 17 Assay kits market, 2018 - 2030 (USD Million)
  • Fig. 18 Analyzers market, 2018 - 2030 (USD Million)
  • Fig. 19 Ancillary products market, 2018 - 2030 (USD Million)
  • Fig. 20 ELISpot and fluorospot assay market: Application segment dashboard
  • Fig. 21 ELISpot and fluorospot assay market: Application market share analysis, 2024 & 2030
  • Fig. 22 Research applications market, 2018 - 2030 (USD Million)
  • Fig. 23 Diagnostics applications market, 2018 - 2030 (USD Million)
  • Fig. 24 ELISpot and fluorospot assay market: End use segment dashboard
  • Fig. 25 ELISpot and fluorospot assay market: End use market share analysis, 2024 & 2030
  • Fig. 26 Hospital and clinical labs market, 2018 - 2030 (USD Million)
  • Fig. 27 Academic and research institutes market, 2018 - 2030 (USD Million)
  • Fig. 28 Biopharmaceutical company market, 2018 - 2030 (USD Million)
  • Fig. 29 ELISpot and fluorospot assay market revenue, by region
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. country dynamics
  • Fig. 34 U.S. ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada country dynamics
  • Fig. 36 Canada ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico country dynamics
  • Fig. 38 Mexico ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 40 UK country dynamics
  • Fig. 41 UK ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 42 Germany country dynamics
  • Fig. 43 Germany ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 44 France country dynamics
  • Fig. 45 France ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 46 Italy country dynamics
  • Fig. 47 Italy ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain country dynamics
  • Fig. 49 Spain ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway country dynamics
  • Fig. 51 Norway ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden country dynamics
  • Fig. 53 Sweden ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark country dynamics
  • Fig. 55 Denmark ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 57 Japan country dynamics
  • Fig. 58 Japan ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 59 China country dynamics
  • Fig. 60 China ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 61 India country dynamics
  • Fig. 62 India ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 63 Australia country dynamics
  • Fig. 64 Australia ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea country dynamics
  • Fig. 66 South Korea ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 67 Thailand country dynamics
  • Fig. 68 Thailand ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 69 Latin America ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil country dynamics
  • Fig. 71 Brazil ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina country dynamics
  • Fig. 73 Argentina ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 74 MEA ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 75 South Africa country dynamics
  • Fig. 76 South Africa ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 77 Saudi Arabia country dynamics
  • Fig. 78 Saudi Arabia ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 79 UAE country dynamics
  • Fig. 80 UAE ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait country dynamics
  • Fig. 82 Kuwait ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 83 Company categorization
  • Fig. 84 Company market position analysis
  • Fig. 85 Strategic framework
目次
Product Code: GVR-4-68040-349-9

ELISpot And Fluorospot Assay Market Trends:

The global ELISpot and fluorospot assay market size was estimated at USD 311.8 million in 2024 and is projected to grow at a CAGR of 6.3% from 2025 to 2030. This growth can be attributed to the rising incidences of chronic and infectious diseases, increasing drug discovery activities, rising adoption in research and diagnostics, and expanding pre-clinical and clinically regulated bioanalysis. The ELISpot and fluorospot assays are used to access immune responses, increasing their importance in understanding the effect of various diseases on the immune system, including cancer.

ELISpot and Fluorospot assay are used to detect and characterize naturally occurring tumor-reactive T-cells, which serve as suitable mediators of cancer immunotherapy. Moreover, these assays are also being used for epitope mapping, identification of tumor antigens, and monitor vaccine-induced T and B-cell responses. Moreover, the development of hepatocellular carcinoma (HCC) and cervical cancer is closely linked to high-risk infections with human papillomavirus (HPV) and hepatitis B virus (HBV), respectively. Tumor-specific vaccines are frequently tested in animal models and cell lines; for example, the HPV vaccine was assessed in mice and cell lines using the IFN-Y and IL-2 ELISPOT assay.

Detection of antigen-specific T cell responses via the IFN-Y ELISPOT assay in a patient with metastatic cervical cancer aids researchers in developing new treatment strategies. Researchers are working to halt cancer progression by inducing tumor-specific cytotoxic T lymphocytes (CTLs) through dendritic cells loaded with tumor DNA or tumor homogenate. Another approach involves generating virus-vectored genetic vaccines, such as using an Adenovirus vector encoding tumor antigens. The response of tumor-specific CTLs can be determined by the ELISPOT assay.

The IFN-Y ELISPOT assay is also used to evaluate the immunological efficacy of high-dose IL-2 treatment in patients with metastatic melanoma and renal cell carcinoma. These increasing applications of ELISpot and Fluorospot assays in cancer research are anticipated to drive their demand with increasing cancer incidences. According to National Cancer Institute data, the number of cancer cases per year is anticipated to increase to 29.9 million and cancer-related deaths to reach 15.3 million. This surge in cancer cases is anticipated to drive the market growth over the forecast period.

These assays provide a powerful tool for assessing a potential drug substance's effect on the immune system. ELISpot is emerging as a critical tool in vaccine development for various conditions, such as immunodeficiency syndrome (AIDS), malaria, tuberculosis, cancer, and flu. The ELISpot test is widely utilized in clinical studies to evaluate vaccines. According to the World Health Organization's (WHO) International Clinical Trials Registry Platform (ICTRP) data, 54,952 clinical trials were performed globally in 2022 alone. These increasing clinical trials and drug discovery activities are expected to increase the demand for ELISpot and Fluorospot assay, thereby driving market growth.

Moreover, several market players are increasing their efforts to develop advanced solutions based on ELISpot and Fluorospot assays for various health conditions, which is further driving the market growth. For instance, in November 2023, Revvity announced the launch of its FDA-approved ELISPOT technology-based T-SPOT test in India for latent TB screening. The test uses a standardized sample, which reduces the influence of blood factors that can impact the test performance and normalization for T-cell count.

Global ELISpot And Fluorospot Assay Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global ELISpot and fluorospot assay market report based on product, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Assay Kits
  • Analyzers
  • Ancillary Products
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Research Applications
  • Diagnostics Applications
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital and Clinical Labs
  • Academic and Research Institutes
  • Biopharmaceutical Company
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. ELISpot and Fluorospot Assay Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. ELISpot and Fluorospot Assay Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Assay Kits
    • 4.4.1. Assay Kits Market, 2018 - 2030 (USD Million)
  • 4.5. Analyzers
    • 4.5.1. Analyzers Market, 2018 - 2030 (USD Million)
  • 4.6. Ancillary Products
    • 4.6.1. Ancillary Products Market, 2018 - 2030 (USD Million)

Chapter 5. ELISpot and Fluorospot Assay Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Research Applications
    • 5.4.1. Research Applications Market, 2018 - 2030 (USD Million)
  • 5.5. Diagnostics Applications
    • 5.5.1. Diagnostics Applications Market, 2018 - 2030 (USD Million)

Chapter 6. ELISpot and Fluorospot Assay Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospital and Clinical Labs
    • 6.4.1. Hospital and Clinical Labs Market, 2018 - 2030 (USD Million)
  • 6.5. Academic and Research Institutes
    • 6.5.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.6. Biopharmaceutical Company
    • 6.6.1. Biopharmaceutical Company Market, 2018 - 2030 (USD Million)

Chapter 7. ELISpot and Fluorospot Assay Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. BD
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. U-CyTech
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Cellular Technology Limited
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Mabtech
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Abcam Limited
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Autoimmun Diagnostika GmbH
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Lophius Biosciences GmbH
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Bio-Connect B.V.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Oxford Immunotec
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Bio-Techne Corporation
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives